The present study aimed to explore the relationship between the level of progesterone receptor expression in serous tumors and small non-coding RNAs, which may act as potential regulators of CA125 and epithelial–mesenchymal transition, influencing the development of an aggressive tumor phenotype and chemoresistance. The gene discussed is PGR; the disease is neoplasm.